Request Demo
Last update 04 Feb 2025
Istituto di Ricovero e Cura a Carattere Scientifico
Last update 04 Feb 2025
Overview
Tags
Nervous System Diseases
Cardiovascular Diseases
Small molecule drug
Disease domain score
A glimpse into the focused therapeutic areas
Technology Platform
Most used technologies in drug development
Targets
Most frequently developed targets
Related
Target |
Mechanism |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication |
Drug Highest Phase |
First Approval Ctry. / Loc. |
First Approval Date |
100 Clinical Results associated with Istituto di Ricovero e Cura a Carattere Scientifico
Login to view more data
Login to view more data
01 Apr 2025SURGERY
Intraoperative ultrasound-guided breast-conserving surgery: A performance analysis on the basis of novel cancer lesion classification and patients' cosmetic satisfaction
Article
Author: Passeri, Daniele ; Del Bianco, Paola ; Milardi, Francesco ; Ferrucci, Massimo ; Grossi, Ugo ; Cagol, Matteo ; Marchet, Alberto
01 Mar 2025ANTI-CANCER DRUGS
Stereotactic body radiotherapy and poly (ADP-ribose) polymerase inhibitors in ovarian cancer: a knowledge and attitudes survey in collaboration with the Italian Association of Radiation Oncology (AIRO) and Multicenter Italian Trials in Ovarian Cancer (MITO) groups
Article
Author: Fanelli, Mara ; Campitelli, Maura ; Pignata, Sandro ; Macchia, Gabriella ; Deodato, Francesco ; Savarese, Antonella ; Gambacorta, Maria Antonietta ; Aristei, Cynthia ; Russo, Donatella ; Pezzulla, Donato ; Fagotti, Anna ; Ferrandina, Gabriella ; Lucci, Simona
01 Feb 2025Pituitary
Empty sella syndrome: an update
Review
Author: De Marinis, Laura ; Bianchi, Antonio ; Giampietro, Antonella ; Chiloiro, Sabrina ; Pontecorvi, Alfredo ; Padovano Sorrentino, Francesco
100 Deals associated with Istituto di Ricovero e Cura a Carattere Scientifico
Login to view more data
100 Translational Medicine associated with Istituto di Ricovero e Cura a Carattere Scientifico
Login to view more data
Corporation Tree
Boost your research with our corporation tree data.
login
or
Pipeline
Pipeline Snapshot as of 05 Apr 2025
The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Preclinical
1
Login to view more data
Current Projects
Login to view more data
Deal
Boost your decision using our deal data.
login
or
Translational Medicine
Boost your research with our translational medicine data.
login
or
Profit
Explore the financial positions of over 360K organizations with Synapse.
login
or
Grant & Funding(NIH)
Access more than 2 million grant and funding information to elevate your research journey.
login
or
Investment
Gain insights on the latest company investments from start-ups to established corporations.
login
or
Financing
Unearth financing trends to validate and advance investment opportunities.
login
or
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free